Cyclo Therapeutics, Inc. (CYTH)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 37.33M |
| Enterprise value | 29.12M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 19.72 |
| Price/book (mrq) | 7.85 |
| Enterprise value/revenue | 27.05 |
| Enterprise value/EBITDA | -1.45 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.15 |
| 52-week change 3 | 36.84% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 2.5700 |
| 52-week low 3 | 0.8400 |
| 50-day moving average 3 | 1.4978 |
| 200-day moving average 3 | 1.4691 |
Share statistics
| Avg vol (3-month) 3 | 106.38k |
| Avg vol (10-day) 3 | 43.53k |
| Shares outstanding 5 | 28.72M |
| Implied shares outstanding 6 | 28.72M |
| Float 8 | 15.87M |
| % held by insiders 1 | 39.48% |
| % held by institutions 1 | 9.76% |
| Shares short (15 Apr 2024) 4 | 75.29k |
| Short ratio (15 Apr 2024) 4 | 0.64 |
| Short % of float (15 Apr 2024) 4 | 0.30% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.26% |
| Shares short (prior month 15 Mar 2024) 4 | 112.59k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 09 Dec 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 09 Dec 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,811.99% |
Management effectiveness
| Return on assets (ttm) | -143.52% |
| Return on equity (ttm) | -730.48% |
Income statement
| Revenue (ttm) | 1.08M |
| Revenue per share (ttm) | 0.07 |
| Quarterly revenue growth (yoy) | 66.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -20.03M |
| Net income avi to common (ttm) | -20.06M |
| Diluted EPS (ttm) | -1.2300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 9.25M |
| Total cash per share (mrq) | 0.32 |
| Total debt (mrq) | 1.03M |
| Total debt/equity (mrq) | 21.72% |
| Current ratio (mrq) | 1.46 |
| Book value per share (mrq) | 0.17 |
Cash flow statement
| Operating cash flow (ttm) | -16.19M |
| Levered free cash flow (ttm) | -8.26M |
© 2024 Yahoo. All rights reserved.